Increase in intraocular pressure found to be tolerable to the corneal endothelium and safe for treating central serous chorioretinopathy or diabetic macular edema.
Jennifer DiSanto
Advertisement
Articles by Jennifer DiSanto
Increased virologic failure and drug resistance following dolutegravir monotherapy prompt researchers to recommend against its use in patients with HIV.
Advances in technology can guide insulin regimens prescribed at discharge among patients with diabetes.
Advertisement
Latest Updated Articles
HIV Monotherapy Shows Substantial Risk of HarmNovember 28th 2017
How Technology Can Improve Diabetes ManagementNovember 27th 2017
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
3
Darovasertib Plus Crizotinib Shows Striking Efficacy in HLA-A2–Negative Metastatic Uveal Melanoma, OptimUM-02 Results Show
4
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
5